FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies

2 hours ago 4

The headquarters of the U.S. Food and Drug Administration in Silver Spring, Maryland, Nov. 4, 2009.

Jason Reed | Reuters

The ⁠Food and Drug ⁠Administration on Thursday Read Entire Article